You have accessed this news story:
OFS - Analyst Notes - July 1, 2020
Helmerich & Payne (NYSE: HP; $21.42-June 22; Buy) Excluding early-termination payments, must acknowledge that we do see negative EBITDA as a very real possibility over the balance of CY’20, and we’re now only modeling marginal positive EBITDA for FY’21 (vs. Street $79MM). Despite that ugly near-term outlook, more important in our view is fact that HP’s healthy balance sheet (Mar-Q net debt/cap ~2%) still offers ample flexibility to weather the storm (and emerge stronger......
Provide your credentials to access this page
Member Area: Log in if you have a PLS web account or Sign up for internet access now.
PLS Web Client?Log in to proceed
|Sign up for PLS Reports
& Web Access!
Already subscribed to Reports?
Sign up for Web Access!